Genetic variation at CR1 increases risk of cerebral amyloid angiopathy.

Abstract

The CR1 variant rs6656401 influences risk and recurrence of CAA-ICH, as well as the severity of vascular amyloid deposition.

Full Text

DOI - Neurology (DOI)
Ovid Technologies, Inc. - full-text online
MD Consult - full-text online
Lippincott Williams & Wilkins - full-text online
HighWire Press - full-text online
Elsevier Science - full-text online

Temas

Artículos similares

Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer's disease and related endophenotypes. (2013-04-10)
Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. (2012-01-24)
Effect of Complement CR1 on Brain Amyloid Burden During Aging and Its Modification by APOE Genotype. (2012-09-27)
Blockage of CR1 prevents activation of rodent microglia. (2013-02-27)
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. (2009-01-23)
Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease. (2012-09-18)
Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission. (2012-09-20)
Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism. (2012-07-21)
Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH. (2012-11-12)

Autores

Fecha de publicación

2012-01-31

Revista

Neurology
Neurology (1526-632X)

Temas de la revista

Idioma

Eng.

Copyright

Neurology

Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.

Referencia de entrega

Neurology. 2012 Jan;78(5):334-41

Libros relacionados

Español | English

© Galenicom 1999-2013